Bacterial Infections Archives - Page 168 of 169 - MPR

Bacterial Infections

MENVEO (meningococcal [Groups A, C, Y, W-135] oligosaccharide diphtheria CRM197 conjugate vaccine)

Menveo meningococcal vaccine approved for children

Novartis announced that the FDA has approved Menveo (meningococcal [Groups A, C, Y and W-135] oligosaccharide diphtheria CRM197 conjugate vaccine) for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in children 2-10 years of age.

Supplemental NDA submitted for Prevnar 13 in older adults

Pfizer announced that it has submitted a supplemental NDA (sNDA) to the FDA to expand the use of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to adults ≥50 years of age for the prevention of pneumococcal disease caused by the 13 serotypes contained in the vaccine.

FDA approves 2-Minute IV injection of Cubicin

Cubist Pharmaceuticals announced that the FDA has approved a new administration method for Cubicin (daptomycin for injection) to include a once-a-day 2-minute intravenous (IV) injection.